Los puntos clave no están disponibles para este artículo en este momento.
Our results emphasize the need of early and complete revascularization in STEMI and non-STEMI, respectively, and of further investigation to inform customized cardioprotective pharmacotherapies in patients with concomitant risk factors and comorbidities, given their risk of developing impaired LVEF.
Eggers et al. (Mon,) studied this question.